Gema Diagnostics' Convertible Note Round

Gema Diagnostics raised a round of funding on September 02, 2013. Investors include Blue Water Angels.

Gema Diagnostics aims to raise IVF birth rates by giving clinicians tools to select the most competent eggs (oocytes) and most viable embryos. GemART, the company's first clinical test, will identify …

Articles about Gema Diagnostics' Convertible Note Round: